Q1 2026 · 13F-HR
Eversept Partners, LPholdings as filed
Filed 2026-05-15 · accession 0001697013-26-000003
$1.90B
Reported value
120
Positions
2026-03-31
Period end
The Brief · Eversept Partners, LP · Q1 2026
AI · grounded in 13F
Eversept Partners, LP closed its position in Danaher Corporation DHR, reducing its exposure by $42.6M. The fund established new positions in QIAGEN NV QGEN for $40.9M and Vertex Pharmaceuticals Inc VRTX for $40.2M. Additionally, the fund accumulated shares in Brookdale Sr Living Inc BKD, increasing its position by 851.8%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $156.7M | 8.26% | 264,271 | Common | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $137.8M | 7.26% | 238,700 | PUT | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $104.0M | 5.49% | 934,423 | Common | SOLE |
| 37733W204 | GSK | GSK PLC | $98.5M | 5.20% | 1,785,175 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $87.4M | 4.61% | 2,173,286 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $76.9M | 4.06% | 384,713 | Common | SOLE |
| 78462F103 | SPY | STATE STR SPDR S&P 500 ETF T | $69.6M | 3.67% | 107,000 | PUT | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $67.4M | 3.55% | 2,885,622 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $56.7M | 2.99% | 1,788,016 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $53.7M | 2.83% | 924,193 | Common | SOLE |
| 112463104 | BKD | BROOKDALE SR LIVING INC | $48.8M | 2.57% | 3,568,555 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $47.5M | 2.50% | 632,100 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $40.2M | 2.12% | 90,000 | CALL | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $37.5M | 1.98% | 79,229 | Common | SOLE |
| 464287432 | TLT | ISHARES TR | $37.2M | 1.96% | 428,800 | PUT | SOLE |
| 95040Q104 | WELL | WELLTOWER INC | $35.8M | 1.89% | 180,953 | Common | SOLE |
| 42250P103 | DOC | HEALTHPEAK PROPERTIES INC | $32.5M | 1.72% | 1,981,070 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $30.1M | 1.59% | 143,546 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $28.9M | 1.53% | 3,039,820 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $28.1M | 1.48% | 18,834,883 | Common | SOLE |
| 681936100 | OHI | OMEGA HEALTHCARE INVS INC | $25.7M | 1.35% | 585,680 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $25.6M | 1.35% | 677,392 | Common | SOLE |
| 203668108 | CYH | COMMUNITY HEALTH SYS INC NEW | $25.5M | 1.35% | 8,677,281 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $23.3M | 1.23% | 2,974,287 | Common | SOLE |
| N72482156 | QGEN | QIAGEN NV | $21.8M | 1.15% | 545,330 | Common | SOLE |
| N72482156 | QGEN | QIAGEN NV | $19.1M | 1.01% | 476,300 | CALL | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $18.8M | 0.99% | 194,104 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $17.5M | 0.92% | 19,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $16.1M | 0.85% | 542,610 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $15.4M | 0.81% | 94,000 | CALL | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC. | $15.0M | 0.79% | 3,188,514 | Common | SOLE |
| 464288513 | HYG | ISHARES TR | $14.3M | 0.76% | 180,000 | PUT | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $14.2M | 0.75% | 120,785 | Common | SOLE |
| 08659B102 | BBNX | BETA BIONICS INC | $14.2M | 0.75% | 1,414,838 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $14.0M | 0.74% | 713,269 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $13.6M | 0.72% | 576,580 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $13.4M | 0.70% | 2,229,446 | Common | SOLE |
| 502175102 | LTC | LTC PPTYS INC | $11.9M | 0.63% | 321,046 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $11.7M | 0.62% | 207,768 | Common | SOLE |
| 16359R103 | CHE | CHEMED CORP NEW | $11.7M | 0.62% | 31,057 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $11.5M | 0.61% | 406,960 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $10.8M | 0.57% | 40,000 | CALL | SOLE |
| 464287655 | IWM | ISHARES TR | $9.9M | 0.52% | 40,000 | PUT | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $9.5M | 0.50% | 312,178 | Common | SOLE |
| 81369Y803 | XLK | SELECT SECTOR SPDR TR | $9.3M | 0.49% | 70,000 | PUT | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $9.1M | 0.48% | 285,764 | Common | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $8.7M | 0.46% | 4,987,499 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $8.1M | 0.43% | 159,708 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $7.8M | 0.41% | 239,110 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $7.6M | 0.40% | 68,688 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $7.5M | 0.40% | 129,574 | Common | SOLE |
| 714046109 | RVTY | REVVITY INC | $7.4M | 0.39% | 84,854 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $6.8M | 0.36% | 200,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $6.7M | 0.35% | 138,036 | Common | SOLE |
| 09073M104 | TECH | BIO-TECHNE CORP | $6.6M | 0.35% | 125,896 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $6.5M | 0.34% | 60,214 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $5.6M | 0.29% | 29,512 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $5.2M | 0.28% | 10,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $5.1M | 0.27% | 11,119 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $4.8M | 0.25% | 14,800 | PUT | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $4.8M | 0.25% | 1,735,963 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $4.4M | 0.23% | 32,811 | Common | SOLE |
| 42226A107 | HQY | HEALTHEQUITY INC | $4.3M | 0.23% | 51,614 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $4.2M | 0.22% | 117,013 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $3.9M | 0.21% | 183,902 | Common | SOLE |
| 78464A870 | XBI | SPDR SERIES TRUST | $3.8M | 0.20% | 30,000 | PUT | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $3.7M | 0.20% | 677,924 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $3.7M | 0.19% | 111,652 | Common | SOLE |
| 00439U104 | GRCE | GRACE THERAPEUTICS INC | $3.5M | 0.18% | 756,600 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $3.5M | 0.18% | 510,543 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $3.3M | 0.17% | 18,200 | PUT | SOLE |
| 29332G102 | EHABUSD | ENHABIT INC | $3.2M | 0.17% | 227,451 | Common | SOLE |
| 81369Y506 | XLE | SELECT SECTOR SPDR TR | $3.1M | 0.16% | 50,000 | CALL | SOLE |
| 24477V105 | DFTX | DEFINIUM THERAPEUTICS INC | $3.0M | 0.16% | 160,723 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $3.0M | 0.16% | 1,498,993 | Common | SOLE |
| 29358P101 | ENSG | ENSIGN GROUP INC | $3.0M | 0.16% | 14,761 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $3.0M | 0.16% | 2,276,349 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $2.9M | 0.15% | 2,348,360 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $2.9M | 0.15% | 1,351,106 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $2.8M | 0.15% | 125,168 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $2.7M | 0.14% | 270,705 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $2.6M | 0.14% | 334,861 | Common | SOLE |
| 50180M108 | LBRX | LB PHARMACEUTICALS INC | $2.5M | 0.13% | 100,198 | Common | SOLE |
| 53630X203 | LPCN | LIPOCINE INC NEW | $2.4M | 0.12% | 294,989 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $2.2M | 0.12% | 250,000 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $2.2M | 0.12% | 401,187 | Common | SOLE |
| 023111404 | AMRN | AMARIN CORP PLC | $2.1M | 0.11% | 147,715 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $2.1M | 0.11% | 384,264 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $1.9M | 0.10% | 277,899 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $1.9M | 0.10% | 146,411 | Common | SOLE |
| 869367201 | STRO | SUTRO BIOPHARMA INC | $1.8M | 0.10% | 73,161 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $1.8M | 0.09% | 1,035,360 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $1.7M | 0.09% | 58,624 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $1.6M | 0.08% | 1,758,573 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $1.5M | 0.08% | 276,174 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $1.5M | 0.08% | 27,089 | Common | SOLE |
| G6674U108 | NVCR | NOVOCURE LTD | $1.5M | 0.08% | 134,917 | Common | SOLE |
| 09075A108 | BVS | BIOVENTUS INC | $1.5M | 0.08% | 159,110 | Common | SOLE |
| 00857U206 | AGL | AGILON HEALTH INC | $1.4M | 0.07% | 176,588 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $1.3M | 0.07% | 62,575 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $1.3M | 0.07% | 54,680 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $1.2M | 0.06% | 39,238 | Common | SOLE |
| 045396207 | ASMB | ASSEMBLY BIOSCIENCES INC | $1.1M | 0.06% | 40,889 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.1M | 0.06% | 891,425 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $1.1M | 0.06% | 136,235 | Common | SOLE |
| 00032Q104 | WHWK | WHITEHAWK THERAPEUTICS INC | $1.1M | 0.06% | 306,800 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $1.0M | 0.05% | 27,055 | Common | SOLE |
| 702712209 | PASG | PASSAGE BIO INC | $1.0M | 0.05% | 131,581 | Common | SOLE |
| 25525P107 | DHC | DIVERSIFIED HEALTHCARE TR | $1.0M | 0.05% | 151,283 | Common | SOLE |
| M5425M103 | INMD | INMODE LTD | $926,738 | 0.05% | 67,744 | Common | SOLE |
| 140475203 | SNDA | SONIDA SENIOR LIVING INC | $917,093 | 0.05% | 28,437 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $884,918 | 0.05% | 190,715 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $718,570 | 0.04% | 290,919 | Common | SOLE |
| 05453U203 | SSII | SS INNOVATIONS INTERNATIONAL | $550,785 | 0.03% | 110,157 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $397,800 | 0.02% | 52,000 | CALL | SOLE |
| 76129W105 | RVP | RETRACTABLE TECHNOLOGIES INC | $384,278 | 0.02% | 580,919 | Common | SOLE |
| 28238P109 | EHTH | EHEALTH INC | $284,980 | 0.02% | 220,915 | Common | SOLE |
| 816307300 | SLQT | SELECTQUOTE INC | $225,148 | 0.01% | 357,661 | Common | SOLE |
| 009496100 | AIRS | AIRSCULPT TECHNOLOGIES INC | $209,813 | 0.01% | 74,139 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $132,566 | 0.01% | 23,800 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.